Expert commentary highlights anti-inflammatory benefits and resistance risks of clindamycin and rifampicin for hidradenitis suppurativa.
We read with great interest the article by Wainman et al., entitled ‘Is there still a role for clindamycin and rifampicin in the treatment of hidradenitis suppurativa? A review of the literature’. We would like to contribute to this important discussion by offering additional clinical perspectives.
No takes yet. Share an insight, caveat, or question.
Toplu et al. (2025) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: